| 11.5 |
34.5 |
GO:0060466 |
activation of meiosis involved in egg activation(GO:0060466) |
| 9.1 |
27.4 |
GO:1904978 |
regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 8.7 |
52.0 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 8.7 |
26.0 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 8.0 |
16.0 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 7.2 |
7.2 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 7.1 |
28.4 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 6.4 |
19.2 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 6.3 |
31.4 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 6.0 |
30.1 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 5.6 |
5.6 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 5.1 |
15.4 |
GO:1904049 |
negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 5.0 |
15.0 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 5.0 |
10.0 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 4.8 |
19.2 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 4.8 |
23.9 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 4.6 |
23.1 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 4.5 |
9.0 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 4.5 |
13.5 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 4.4 |
39.9 |
GO:0097107 |
postsynaptic density assembly(GO:0097107) |
| 4.3 |
13.0 |
GO:0031335 |
regulation of sulfur amino acid metabolic process(GO:0031335) |
| 4.3 |
4.3 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
| 4.2 |
12.7 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 4.2 |
4.2 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 4.2 |
12.6 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 4.1 |
12.3 |
GO:0003195 |
tricuspid valve formation(GO:0003195) |
| 4.1 |
4.1 |
GO:1904048 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 4.0 |
59.6 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 4.0 |
23.7 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 3.8 |
7.7 |
GO:0021649 |
vestibulocochlear nerve structural organization(GO:0021649) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) ganglion morphogenesis(GO:0061552) facioacoustic ganglion development(GO:1903375) dorsal root ganglion morphogenesis(GO:1904835) |
| 3.8 |
30.3 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 3.8 |
15.0 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 3.7 |
26.0 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 3.7 |
11.0 |
GO:1905223 |
epicardium morphogenesis(GO:1905223) |
| 3.7 |
11.0 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 3.6 |
14.6 |
GO:1903943 |
regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 3.6 |
10.9 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 3.6 |
7.2 |
GO:0070671 |
response to interleukin-12(GO:0070671) |
| 3.6 |
32.3 |
GO:1900034 |
regulation of cellular response to heat(GO:1900034) |
| 3.6 |
17.8 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 3.6 |
17.8 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 3.6 |
67.5 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 3.4 |
10.3 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 3.4 |
13.6 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 3.4 |
23.8 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 3.4 |
10.1 |
GO:0039533 |
regulation of MDA-5 signaling pathway(GO:0039533) |
| 3.3 |
10.0 |
GO:0060023 |
soft palate development(GO:0060023) |
| 3.3 |
13.2 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 3.3 |
9.8 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 3.3 |
13.0 |
GO:0021586 |
pons maturation(GO:0021586) |
| 3.2 |
22.7 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 3.2 |
16.2 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 3.2 |
19.4 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 3.1 |
25.2 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 3.1 |
6.3 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 3.1 |
12.3 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 3.1 |
15.4 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 3.1 |
12.3 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 3.1 |
12.3 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 3.0 |
6.1 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 3.0 |
6.1 |
GO:1905075 |
occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 3.0 |
6.0 |
GO:0097112 |
gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 3.0 |
9.0 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 3.0 |
11.8 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 2.9 |
11.8 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 2.9 |
14.7 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 2.9 |
2.9 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 2.9 |
29.3 |
GO:0046959 |
habituation(GO:0046959) |
| 2.9 |
5.9 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 2.9 |
8.8 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 2.9 |
20.3 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 2.9 |
11.6 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 2.9 |
26.1 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 2.9 |
8.7 |
GO:0098928 |
presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 2.9 |
2.9 |
GO:0030818 |
negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) negative regulation of cAMP biosynthetic process(GO:0030818) |
| 2.9 |
8.6 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 2.8 |
8.5 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 2.8 |
19.6 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 2.8 |
8.3 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 2.7 |
19.2 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
| 2.7 |
5.5 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 2.7 |
5.4 |
GO:0061744 |
motor behavior(GO:0061744) |
| 2.7 |
10.8 |
GO:0035937 |
estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 2.7 |
5.4 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 2.7 |
13.4 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 2.7 |
2.7 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 2.6 |
10.5 |
GO:0099527 |
postsynapse to nucleus signaling pathway(GO:0099527) |
| 2.6 |
18.3 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 2.6 |
26.1 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 2.6 |
7.7 |
GO:1902514 |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 2.6 |
12.8 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 2.5 |
7.6 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 2.5 |
7.6 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 2.5 |
7.6 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 2.5 |
15.0 |
GO:0033139 |
regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 2.5 |
7.5 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 2.5 |
29.8 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 2.5 |
7.5 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 2.5 |
7.4 |
GO:0060997 |
dendritic spine morphogenesis(GO:0060997) |
| 2.5 |
12.3 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 2.4 |
7.3 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 2.4 |
7.3 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 2.4 |
2.4 |
GO:2000137 |
negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
| 2.4 |
14.4 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 2.4 |
4.8 |
GO:0014735 |
regulation of muscle atrophy(GO:0014735) |
| 2.4 |
7.1 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 2.4 |
19.0 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 2.4 |
9.4 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
| 2.3 |
7.0 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 2.3 |
32.6 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 2.3 |
7.0 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 2.3 |
25.6 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 2.3 |
7.0 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 2.3 |
9.3 |
GO:1903860 |
negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
| 2.3 |
2.3 |
GO:1904179 |
positive regulation of adipose tissue development(GO:1904179) |
| 2.3 |
2.3 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 2.3 |
22.9 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 2.3 |
18.2 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 2.2 |
9.0 |
GO:0099590 |
neurotransmitter receptor internalization(GO:0099590) |
| 2.2 |
4.5 |
GO:0060849 |
regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 2.2 |
2.2 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 2.2 |
15.5 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 2.2 |
11.0 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 2.2 |
6.6 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 2.2 |
10.9 |
GO:1903818 |
positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 2.2 |
2.2 |
GO:0061549 |
sympathetic ganglion development(GO:0061549) |
| 2.2 |
10.9 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 2.2 |
10.9 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 2.2 |
13.1 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 2.2 |
15.1 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 2.2 |
17.2 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 2.1 |
8.6 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 2.1 |
8.6 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 2.1 |
6.4 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 2.1 |
8.5 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 2.1 |
2.1 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 2.1 |
6.4 |
GO:0021764 |
amygdala development(GO:0021764) |
| 2.1 |
8.5 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 2.1 |
12.8 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 2.1 |
8.5 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
| 2.1 |
6.3 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 2.1 |
16.9 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 2.1 |
2.1 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 2.1 |
8.4 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 2.1 |
12.4 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 2.0 |
30.4 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 2.0 |
8.0 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 2.0 |
8.0 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 2.0 |
5.9 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 2.0 |
15.7 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 2.0 |
9.8 |
GO:0035984 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 2.0 |
29.3 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 1.9 |
9.6 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 1.9 |
9.6 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 1.9 |
9.6 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 1.9 |
23.1 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 1.9 |
7.6 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 1.9 |
3.8 |
GO:0046878 |
positive regulation of saliva secretion(GO:0046878) |
| 1.9 |
17.0 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 1.9 |
18.8 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 1.9 |
1.9 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 1.9 |
20.5 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 1.9 |
11.2 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 1.9 |
1.9 |
GO:0046619 |
optic placode formation involved in camera-type eye formation(GO:0046619) |
| 1.8 |
5.5 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.8 |
29.5 |
GO:1903859 |
regulation of dendrite extension(GO:1903859) |
| 1.8 |
16.6 |
GO:0021960 |
anterior commissure morphogenesis(GO:0021960) |
| 1.8 |
5.5 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 1.8 |
1.8 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 1.8 |
12.5 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 1.8 |
3.6 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 1.8 |
10.6 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 1.8 |
14.0 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 1.7 |
3.5 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 1.7 |
15.7 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 1.7 |
10.4 |
GO:1901911 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 1.7 |
6.9 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 1.7 |
1.7 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 1.7 |
24.0 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 1.7 |
3.4 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 1.7 |
6.8 |
GO:0097393 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 1.7 |
3.4 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 1.7 |
5.1 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 1.7 |
5.1 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 1.7 |
8.4 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 1.7 |
8.4 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 1.7 |
8.4 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 1.7 |
3.3 |
GO:0048687 |
positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
| 1.7 |
6.7 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 1.7 |
6.7 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 1.7 |
9.9 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 1.7 |
1.7 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 1.6 |
3.3 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 1.6 |
4.9 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 1.6 |
4.9 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 1.6 |
4.9 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 1.6 |
8.2 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 1.6 |
6.5 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 1.6 |
11.4 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.6 |
4.9 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 1.6 |
4.9 |
GO:0035523 |
protein K29-linked deubiquitination(GO:0035523) |
| 1.6 |
4.9 |
GO:0015866 |
ADP transport(GO:0015866) |
| 1.6 |
13.0 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) |
| 1.6 |
6.5 |
GO:0021604 |
cranial nerve structural organization(GO:0021604) |
| 1.6 |
4.8 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.6 |
14.4 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 1.6 |
1.6 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 1.6 |
1.6 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 1.6 |
20.7 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 1.6 |
4.8 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 1.6 |
3.2 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 1.6 |
1.6 |
GO:0003383 |
apical constriction(GO:0003383) |
| 1.6 |
6.3 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 1.6 |
4.7 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 1.6 |
62.7 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 1.6 |
4.7 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 1.6 |
4.7 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 1.6 |
4.7 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 1.5 |
3.1 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 1.5 |
12.4 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 1.5 |
4.6 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 1.5 |
1.5 |
GO:0065001 |
specification of axis polarity(GO:0065001) |
| 1.5 |
7.7 |
GO:0015871 |
choline transport(GO:0015871) |
| 1.5 |
18.3 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 1.5 |
9.2 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 1.5 |
32.0 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 1.5 |
4.6 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 1.5 |
21.3 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 1.5 |
9.1 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 1.5 |
1.5 |
GO:2000807 |
regulation of synaptic vesicle clustering(GO:2000807) |
| 1.5 |
9.0 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 1.5 |
4.5 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 1.5 |
4.5 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.5 |
1.5 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 1.5 |
4.5 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 1.5 |
7.4 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 1.5 |
4.5 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 1.5 |
7.4 |
GO:0070494 |
regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 1.5 |
10.3 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 1.5 |
5.9 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 1.5 |
1.5 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 1.5 |
13.1 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 1.4 |
7.2 |
GO:1902732 |
positive regulation of chondrocyte proliferation(GO:1902732) |
| 1.4 |
2.9 |
GO:0038095 |
Fc-epsilon receptor signaling pathway(GO:0038095) |
| 1.4 |
4.3 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 1.4 |
8.6 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 1.4 |
13.0 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 1.4 |
5.7 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 1.4 |
8.5 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 1.4 |
10.0 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 1.4 |
4.2 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 1.4 |
1.4 |
GO:0031645 |
negative regulation of neurological system process(GO:0031645) |
| 1.4 |
8.4 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 1.4 |
5.6 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 1.4 |
5.6 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 1.4 |
4.2 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 1.4 |
4.2 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 1.4 |
2.8 |
GO:0033003 |
regulation of mast cell activation(GO:0033003) |
| 1.4 |
5.5 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 1.4 |
2.8 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 1.4 |
39.9 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 1.4 |
9.6 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 1.4 |
8.2 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 1.4 |
4.1 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 1.4 |
8.2 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 1.4 |
4.1 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 1.4 |
9.5 |
GO:0030242 |
pexophagy(GO:0030242) |
| 1.3 |
5.4 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 1.3 |
53.8 |
GO:0046928 |
regulation of neurotransmitter secretion(GO:0046928) |
| 1.3 |
1.3 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 1.3 |
34.8 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 1.3 |
2.7 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.3 |
6.7 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 1.3 |
1.3 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 1.3 |
2.7 |
GO:1904580 |
regulation of intracellular mRNA localization(GO:1904580) |
| 1.3 |
1.3 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) |
| 1.3 |
1.3 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 1.3 |
1.3 |
GO:0071073 |
positive regulation of phospholipid biosynthetic process(GO:0071073) |
| 1.3 |
1.3 |
GO:0045410 |
positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 1.3 |
5.2 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 1.3 |
5.2 |
GO:0098937 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 1.3 |
28.4 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 1.3 |
3.9 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 1.3 |
9.0 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 1.3 |
10.2 |
GO:0010642 |
negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 1.3 |
6.4 |
GO:0061734 |
parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 1.3 |
3.8 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 1.3 |
2.5 |
GO:0044860 |
protein localization to plasma membrane raft(GO:0044860) |
| 1.3 |
2.5 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 1.3 |
3.8 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 1.3 |
1.3 |
GO:1990859 |
cellular response to endothelin(GO:1990859) |
| 1.3 |
11.3 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 1.3 |
32.7 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 1.3 |
8.8 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 1.3 |
7.5 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 1.2 |
3.7 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 1.2 |
3.7 |
GO:0098885 |
actin filament bundle distribution(GO:0070650) modification of postsynaptic actin cytoskeleton(GO:0098885) |
| 1.2 |
8.7 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 1.2 |
5.0 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 1.2 |
4.9 |
GO:0033092 |
positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 1.2 |
17.2 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 1.2 |
3.7 |
GO:1905247 |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 1.2 |
3.7 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 1.2 |
3.7 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 1.2 |
12.2 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 1.2 |
2.4 |
GO:1903978 |
regulation of microglial cell activation(GO:1903978) |
| 1.2 |
2.4 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 1.2 |
9.7 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 1.2 |
1.2 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 1.2 |
4.9 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 1.2 |
8.5 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 1.2 |
7.3 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 1.2 |
16.9 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 1.2 |
9.6 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 1.2 |
30.1 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 1.2 |
7.2 |
GO:1902741 |
type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 1.2 |
3.6 |
GO:0019389 |
glucuronoside metabolic process(GO:0019389) |
| 1.2 |
1.2 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 1.2 |
1.2 |
GO:1903430 |
negative regulation of cell maturation(GO:1903430) |
| 1.2 |
2.4 |
GO:0072053 |
renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 1.2 |
4.7 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 1.2 |
4.7 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 1.2 |
17.5 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 1.2 |
15.1 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 1.2 |
2.3 |
GO:0042939 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) drug export(GO:0046618) |
| 1.2 |
3.5 |
GO:0045924 |
regulation of female receptivity(GO:0045924) |
| 1.1 |
4.6 |
GO:0070197 |
meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 1.1 |
3.4 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 1.1 |
3.4 |
GO:0048007 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 1.1 |
6.9 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.1 |
2.3 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 1.1 |
9.1 |
GO:0098712 |
L-glutamate import across plasma membrane(GO:0098712) |
| 1.1 |
1.1 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 1.1 |
5.7 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 1.1 |
1.1 |
GO:2000830 |
vacuolar phosphate transport(GO:0007037) vitamin D3 metabolic process(GO:0070640) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 1.1 |
10.1 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of RNA export from nucleus(GO:0046831) |
| 1.1 |
6.7 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 1.1 |
10.0 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 1.1 |
1.1 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 1.1 |
2.2 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 1.1 |
7.8 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 1.1 |
1.1 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 1.1 |
8.8 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 1.1 |
2.2 |
GO:2000586 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
| 1.1 |
3.3 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 1.1 |
5.4 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 1.1 |
4.3 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 1.1 |
5.4 |
GO:0072367 |
regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 1.1 |
3.2 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 1.1 |
15.0 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 1.1 |
7.5 |
GO:0071971 |
extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
| 1.1 |
3.2 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 1.1 |
1.1 |
GO:0003134 |
BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
| 1.1 |
5.3 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 1.1 |
1.1 |
GO:1902256 |
apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 1.1 |
6.4 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 1.1 |
6.3 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 1.1 |
3.2 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 1.1 |
4.2 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 1.1 |
1.1 |
GO:0034764 |
positive regulation of transmembrane transport(GO:0034764) |
| 1.1 |
6.3 |
GO:1903056 |
melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 1.1 |
5.3 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 1.1 |
1.1 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 1.0 |
6.3 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 1.0 |
1.0 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 1.0 |
3.1 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 1.0 |
3.1 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 1.0 |
12.3 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 1.0 |
36.9 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 1.0 |
3.1 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 1.0 |
11.2 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 1.0 |
2.0 |
GO:1904504 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 1.0 |
7.1 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 1.0 |
7.1 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 1.0 |
69.3 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 1.0 |
1.0 |
GO:0052151 |
modulation by symbiont of host apoptotic process(GO:0052150) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 1.0 |
3.0 |
GO:0090148 |
membrane fission(GO:0090148) |
| 1.0 |
4.0 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 1.0 |
3.0 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 1.0 |
3.0 |
GO:0071638 |
negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 1.0 |
14.0 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 1.0 |
7.0 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 1.0 |
1.0 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 1.0 |
7.0 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 1.0 |
5.0 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 1.0 |
6.9 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 1.0 |
4.0 |
GO:0048524 |
positive regulation of viral process(GO:0048524) |
| 1.0 |
2.0 |
GO:0099566 |
regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 1.0 |
1.0 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 1.0 |
2.9 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) retrograde trans-synaptic signaling(GO:0098917) |
| 1.0 |
2.9 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 1.0 |
5.8 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 1.0 |
1.0 |
GO:0060003 |
copper ion export(GO:0060003) |
| 1.0 |
1.0 |
GO:0034398 |
telomere tethering at nuclear periphery(GO:0034398) |
| 1.0 |
3.9 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 1.0 |
1.9 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 1.0 |
3.8 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 1.0 |
1.9 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 1.0 |
20.1 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 1.0 |
6.7 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.9 |
2.8 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.9 |
3.8 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.9 |
3.8 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.9 |
1.9 |
GO:0071440 |
regulation of histone H3-K14 acetylation(GO:0071440) |
| 0.9 |
1.9 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.9 |
2.8 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.9 |
12.1 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.9 |
0.9 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.9 |
11.1 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.9 |
1.9 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.9 |
0.9 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.9 |
3.7 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.9 |
6.4 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.9 |
8.3 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) |
| 0.9 |
27.5 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.9 |
8.2 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.9 |
0.9 |
GO:1905165 |
peptidyl-aspartic acid modification(GO:0018197) regulation of lysosomal protein catabolic process(GO:1905165) |
| 0.9 |
10.8 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.9 |
1.8 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.9 |
1.8 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.9 |
8.1 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.9 |
1.8 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.9 |
6.3 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.9 |
1.8 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
| 0.9 |
1.8 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.9 |
4.5 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.9 |
2.7 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.9 |
1.8 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.9 |
12.4 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 0.9 |
8.8 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.9 |
3.5 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.9 |
4.4 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.9 |
0.9 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.9 |
0.9 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.9 |
1.7 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.9 |
1.7 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.9 |
16.5 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.9 |
3.5 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.9 |
1.7 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.9 |
11.2 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.9 |
1.7 |
GO:0032958 |
inositol phosphate biosynthetic process(GO:0032958) |
| 0.9 |
3.4 |
GO:1904953 |
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.9 |
3.4 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.9 |
6.0 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.9 |
31.5 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.8 |
1.7 |
GO:1903207 |
neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.8 |
4.2 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.8 |
3.4 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.8 |
0.8 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.8 |
2.5 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.8 |
6.7 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.8 |
10.0 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.8 |
1.7 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.8 |
0.8 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 0.8 |
1.7 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.8 |
30.0 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.8 |
15.7 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.8 |
2.5 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.8 |
8.2 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.8 |
2.5 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.8 |
1.6 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.8 |
1.6 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.8 |
4.9 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.8 |
4.1 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.8 |
3.2 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.8 |
0.8 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.8 |
4.8 |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.8 |
0.8 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.8 |
2.4 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.8 |
3.2 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.8 |
4.0 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.8 |
3.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.8 |
8.6 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.8 |
2.4 |
GO:0072554 |
blood vessel lumenization(GO:0072554) |
| 0.8 |
1.6 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.8 |
9.4 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.8 |
13.3 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.8 |
3.9 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.8 |
1.6 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.8 |
6.2 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.8 |
2.3 |
GO:0001828 |
inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.8 |
5.4 |
GO:0006678 |
glucosylceramide metabolic process(GO:0006678) |
| 0.8 |
1.5 |
GO:1900223 |
positive regulation of beta-amyloid clearance(GO:1900223) |
| 0.8 |
0.8 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.8 |
1.5 |
GO:0031554 |
regulation of DNA-templated transcription, termination(GO:0031554) |
| 0.8 |
0.8 |
GO:0050904 |
diapedesis(GO:0050904) |
| 0.8 |
8.5 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.8 |
3.9 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.8 |
6.1 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.8 |
6.9 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.8 |
0.8 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.8 |
8.4 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.8 |
10.6 |
GO:0021535 |
cell migration in hindbrain(GO:0021535) |
| 0.8 |
6.8 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.8 |
12.0 |
GO:0050872 |
white fat cell differentiation(GO:0050872) |
| 0.8 |
99.8 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.7 |
3.7 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.7 |
1.5 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.7 |
6.7 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.7 |
20.1 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.7 |
4.4 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.7 |
1.5 |
GO:0051095 |
regulation of helicase activity(GO:0051095) |
| 0.7 |
0.7 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 0.7 |
4.4 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.7 |
3.6 |
GO:0051281 |
positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.7 |
0.7 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.7 |
2.9 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.7 |
2.2 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.7 |
2.2 |
GO:0032225 |
regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.7 |
23.0 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.7 |
3.6 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.7 |
2.1 |
GO:1904684 |
negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.7 |
0.7 |
GO:0071317 |
cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.7 |
5.7 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.7 |
4.2 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.7 |
4.2 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.7 |
8.4 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.7 |
2.1 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.7 |
3.5 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.7 |
12.5 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.7 |
3.5 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.7 |
5.5 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.7 |
1.4 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.7 |
2.1 |
GO:0072530 |
purine-containing compound transmembrane transport(GO:0072530) |
| 0.7 |
0.7 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.7 |
3.4 |
GO:0097178 |
ruffle assembly(GO:0097178) |
| 0.7 |
2.7 |
GO:1900449 |
regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.7 |
8.7 |
GO:0002446 |
neutrophil mediated immunity(GO:0002446) |
| 0.7 |
8.0 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.7 |
4.6 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.7 |
3.9 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.7 |
5.2 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.7 |
3.9 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.7 |
1.3 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.6 |
6.5 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.6 |
1.9 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.6 |
1.3 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.6 |
1.3 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 0.6 |
5.8 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.6 |
4.5 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.6 |
0.6 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.6 |
1.3 |
GO:0090494 |
catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.6 |
4.5 |
GO:0097369 |
sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.6 |
5.1 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.6 |
5.1 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.6 |
24.9 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.6 |
1.9 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.6 |
1.9 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.6 |
0.6 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.6 |
2.5 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.6 |
0.6 |
GO:0010896 |
regulation of triglyceride catabolic process(GO:0010896) |
| 0.6 |
4.4 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.6 |
13.7 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.6 |
5.0 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.6 |
0.6 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.6 |
4.9 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.6 |
2.5 |
GO:0006497 |
protein lipidation(GO:0006497) |
| 0.6 |
6.1 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.6 |
0.6 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) |
| 0.6 |
10.4 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.6 |
0.6 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.6 |
1.8 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.6 |
6.6 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.6 |
4.2 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.6 |
1.8 |
GO:0034350 |
regulation of glial cell apoptotic process(GO:0034350) |
| 0.6 |
10.8 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 0.6 |
1.8 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.6 |
1.2 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.6 |
1.8 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.6 |
1.2 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.6 |
7.0 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.6 |
2.9 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.6 |
1.7 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.6 |
2.3 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.6 |
1.7 |
GO:0060509 |
Type I pneumocyte differentiation(GO:0060509) |
| 0.6 |
1.7 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.6 |
0.6 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.6 |
4.0 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.6 |
5.1 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.6 |
0.6 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.6 |
9.0 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.6 |
1.7 |
GO:0060965 |
negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.6 |
4.5 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.6 |
5.1 |
GO:0044144 |
regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.6 |
12.9 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.6 |
2.2 |
GO:0016128 |
phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.6 |
9.5 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.6 |
3.9 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.6 |
1.1 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.6 |
0.6 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.6 |
3.3 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.6 |
8.9 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.6 |
1.7 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 0.6 |
2.2 |
GO:0046834 |
lipid phosphorylation(GO:0046834) |
| 0.6 |
1.7 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.6 |
2.8 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.6 |
1.1 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 0.6 |
5.0 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.6 |
2.2 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.5 |
0.5 |
GO:0003307 |
regulation of Wnt signaling pathway involved in heart development(GO:0003307) |
| 0.5 |
0.5 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.5 |
2.7 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.5 |
0.5 |
GO:0080144 |
amino acid homeostasis(GO:0080144) |
| 0.5 |
1.6 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.5 |
1.1 |
GO:2000401 |
regulation of lymphocyte migration(GO:2000401) |
| 0.5 |
0.5 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.5 |
2.1 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.5 |
0.5 |
GO:0071211 |
protein targeting to vacuole involved in autophagy(GO:0071211) |
| 0.5 |
1.6 |
GO:1903044 |
protein transport into membrane raft(GO:0032596) protein localization to membrane raft(GO:1903044) |
| 0.5 |
6.3 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.5 |
1.6 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.5 |
0.5 |
GO:2000314 |
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.5 |
1.6 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.5 |
5.2 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.5 |
1.5 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.5 |
0.5 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.5 |
1.5 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.5 |
4.1 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.5 |
2.0 |
GO:0043407 |
negative regulation of MAP kinase activity(GO:0043407) |
| 0.5 |
2.0 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.5 |
1.0 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
| 0.5 |
1.5 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.5 |
3.5 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.5 |
2.5 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.5 |
0.5 |
GO:0042501 |
serine phosphorylation of STAT protein(GO:0042501) |
| 0.5 |
14.5 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.5 |
1.5 |
GO:0090004 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.5 |
2.0 |
GO:0047497 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.5 |
1.5 |
GO:0071071 |
regulation of phospholipid biosynthetic process(GO:0071071) |
| 0.5 |
2.5 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.5 |
2.5 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.5 |
3.4 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.5 |
0.5 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 0.5 |
10.7 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.5 |
1.0 |
GO:0090218 |
positive regulation of lipid kinase activity(GO:0090218) |
| 0.5 |
1.4 |
GO:0072720 |
response to dithiothreitol(GO:0072720) |
| 0.5 |
1.0 |
GO:0003171 |
atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
| 0.5 |
2.4 |
GO:0014010 |
Schwann cell proliferation(GO:0014010) |
| 0.5 |
1.4 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.5 |
2.9 |
GO:0021670 |
lateral ventricle development(GO:0021670) |
| 0.5 |
6.7 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.5 |
1.4 |
GO:2000318 |
T-helper 2 cell activation(GO:0035712) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.5 |
7.1 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.5 |
1.4 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.5 |
4.7 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.5 |
2.4 |
GO:0032303 |
regulation of icosanoid secretion(GO:0032303) |
| 0.5 |
0.9 |
GO:0010958 |
regulation of amino acid import(GO:0010958) |
| 0.5 |
7.9 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.5 |
5.6 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.5 |
3.7 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.5 |
4.2 |
GO:0051932 |
synaptic transmission, GABAergic(GO:0051932) |
| 0.5 |
25.4 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.5 |
16.5 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.5 |
2.3 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.5 |
1.4 |
GO:0043302 |
positive regulation of leukocyte degranulation(GO:0043302) |
| 0.5 |
1.4 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.5 |
0.5 |
GO:0060702 |
negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.5 |
6.8 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.5 |
3.2 |
GO:1902305 |
regulation of sodium ion transmembrane transport(GO:1902305) |
| 0.5 |
4.1 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.4 |
3.6 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.4 |
1.3 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.4 |
0.9 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.4 |
2.7 |
GO:0072666 |
establishment of protein localization to vacuole(GO:0072666) |
| 0.4 |
1.8 |
GO:1904672 |
regulation of somatic stem cell population maintenance(GO:1904672) |
| 0.4 |
6.2 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.4 |
11.5 |
GO:0099643 |
neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
| 0.4 |
1.3 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.4 |
0.9 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.4 |
2.6 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.4 |
13.2 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.4 |
0.4 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.4 |
6.1 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.4 |
8.8 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.4 |
2.6 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.4 |
0.4 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.4 |
0.9 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.4 |
2.2 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.4 |
3.0 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.4 |
1.7 |
GO:0061001 |
regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.4 |
3.0 |
GO:0071926 |
endocannabinoid signaling pathway(GO:0071926) |
| 0.4 |
1.3 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.4 |
1.3 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.4 |
0.9 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.4 |
1.7 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.4 |
1.7 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.4 |
2.1 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.4 |
0.8 |
GO:2000836 |
positive regulation of androgen secretion(GO:2000836) positive regulation of testosterone secretion(GO:2000845) |
| 0.4 |
0.8 |
GO:0045346 |
regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.4 |
1.7 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.4 |
2.1 |
GO:0042160 |
plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.4 |
1.2 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.4 |
5.3 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.4 |
2.0 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.4 |
0.8 |
GO:0035630 |
bone mineralization involved in bone maturation(GO:0035630) |
| 0.4 |
3.2 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.4 |
6.9 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.4 |
1.2 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.4 |
2.4 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.4 |
27.6 |
GO:0035308 |
negative regulation of protein dephosphorylation(GO:0035308) |
| 0.4 |
0.8 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.4 |
4.4 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.4 |
4.8 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.4 |
1.2 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.4 |
2.4 |
GO:0070861 |
regulation of protein exit from endoplasmic reticulum(GO:0070861) |
| 0.4 |
2.0 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.4 |
0.4 |
GO:0051956 |
negative regulation of amino acid transport(GO:0051956) |
| 0.4 |
0.4 |
GO:0031282 |
regulation of guanylate cyclase activity(GO:0031282) |
| 0.4 |
0.4 |
GO:0090646 |
mitochondrial tRNA processing(GO:0090646) |
| 0.4 |
2.0 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.4 |
20.3 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.4 |
2.7 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.4 |
2.7 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.4 |
0.4 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.4 |
1.2 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.4 |
0.8 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.4 |
0.8 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.4 |
1.5 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.4 |
3.4 |
GO:0030826 |
regulation of cGMP biosynthetic process(GO:0030826) |
| 0.4 |
1.5 |
GO:0042220 |
response to cocaine(GO:0042220) |
| 0.4 |
1.1 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.4 |
2.3 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.4 |
3.8 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.4 |
2.3 |
GO:1904181 |
positive regulation of membrane depolarization(GO:1904181) |
| 0.4 |
0.8 |
GO:1903912 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.4 |
3.0 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.4 |
0.7 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.4 |
4.1 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.4 |
2.2 |
GO:0099500 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.4 |
2.2 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.4 |
1.5 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.4 |
1.8 |
GO:0030952 |
establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.4 |
1.1 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.4 |
2.2 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.4 |
2.5 |
GO:0010954 |
positive regulation of protein processing(GO:0010954) |
| 0.4 |
1.4 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.4 |
2.5 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.4 |
4.6 |
GO:0019076 |
viral release from host cell(GO:0019076) |
| 0.4 |
3.9 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.4 |
1.8 |
GO:0097113 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.4 |
9.6 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.4 |
24.4 |
GO:0036503 |
ERAD pathway(GO:0036503) |
| 0.4 |
0.7 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.4 |
1.4 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.4 |
2.5 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.3 |
1.7 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.3 |
0.7 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.3 |
6.6 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.3 |
3.1 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.3 |
1.7 |
GO:2000008 |
regulation of protein localization to cell surface(GO:2000008) |
| 0.3 |
1.0 |
GO:2000110 |
protein sialylation(GO:1990743) negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.3 |
4.8 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.3 |
2.7 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.3 |
3.1 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.3 |
0.7 |
GO:0001504 |
neurotransmitter uptake(GO:0001504) |
| 0.3 |
2.0 |
GO:0051209 |
release of sequestered calcium ion into cytosol(GO:0051209) negative regulation of sequestering of calcium ion(GO:0051283) |
| 0.3 |
0.3 |
GO:0099630 |
postsynaptic neurotransmitter receptor cycle(GO:0099630) neurotransmitter receptor transport(GO:0099637) |
| 0.3 |
3.4 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 0.3 |
1.7 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.3 |
1.7 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.3 |
1.0 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 |
1.3 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.3 |
32.5 |
GO:0006813 |
potassium ion transport(GO:0006813) |
| 0.3 |
1.3 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.3 |
3.0 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.3 |
1.0 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.3 |
1.0 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.3 |
0.7 |
GO:0010820 |
regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
| 0.3 |
0.7 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.3 |
0.6 |
GO:0006688 |
glycosphingolipid biosynthetic process(GO:0006688) |
| 0.3 |
2.3 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.3 |
22.6 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.3 |
1.3 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.3 |
0.6 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.3 |
3.2 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.3 |
4.1 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.3 |
0.3 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.3 |
4.7 |
GO:0030149 |
sphingolipid catabolic process(GO:0030149) |
| 0.3 |
0.9 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.3 |
0.3 |
GO:0070230 |
positive regulation of lymphocyte apoptotic process(GO:0070230) |
| 0.3 |
1.2 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 0.3 |
1.6 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.3 |
0.3 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.3 |
1.2 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.3 |
2.2 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.3 |
6.8 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.3 |
1.8 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.3 |
3.3 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.3 |
5.2 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.3 |
1.8 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.3 |
0.6 |
GO:0051788 |
response to misfolded protein(GO:0051788) |
| 0.3 |
0.9 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.3 |
2.1 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.3 |
0.6 |
GO:0046113 |
nucleobase catabolic process(GO:0046113) |
| 0.3 |
2.6 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) |
| 0.3 |
0.3 |
GO:0043928 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.3 |
0.6 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.3 |
1.4 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.3 |
0.6 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.3 |
4.0 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.3 |
0.3 |
GO:0045324 |
late endosome to vacuole transport(GO:0045324) |
| 0.3 |
1.1 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.3 |
1.1 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.3 |
3.4 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.3 |
1.4 |
GO:0031034 |
myosin filament assembly(GO:0031034) |
| 0.3 |
0.3 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.3 |
1.1 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.3 |
4.2 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.3 |
0.8 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.3 |
0.8 |
GO:0015824 |
proline transport(GO:0015824) |
| 0.3 |
0.8 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.3 |
0.8 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.3 |
1.4 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.3 |
3.0 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.3 |
0.8 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.3 |
24.7 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.3 |
0.3 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.3 |
0.3 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.3 |
4.4 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
| 0.3 |
1.6 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 0.3 |
1.4 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.3 |
5.4 |
GO:0032418 |
lysosome localization(GO:0032418) |
| 0.3 |
0.3 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.3 |
4.8 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.3 |
0.5 |
GO:0034312 |
diol biosynthetic process(GO:0034312) |
| 0.3 |
2.1 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.3 |
0.3 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.3 |
0.3 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.3 |
9.9 |
GO:0006672 |
ceramide metabolic process(GO:0006672) |
| 0.3 |
0.8 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.3 |
1.8 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.3 |
2.3 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.3 |
0.3 |
GO:0032346 |
positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
| 0.3 |
0.8 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.3 |
3.1 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.3 |
1.3 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.3 |
8.9 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.3 |
1.0 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.3 |
0.8 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.3 |
0.8 |
GO:0008105 |
asymmetric protein localization(GO:0008105) |
| 0.3 |
2.5 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.3 |
4.0 |
GO:0018279 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.3 |
0.5 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.3 |
1.5 |
GO:0090280 |
positive regulation of calcium ion import(GO:0090280) |
| 0.3 |
0.5 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.2 |
4.7 |
GO:0035065 |
regulation of histone acetylation(GO:0035065) |
| 0.2 |
1.5 |
GO:0060004 |
reflex(GO:0060004) |
| 0.2 |
1.0 |
GO:1903028 |
regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
| 0.2 |
1.7 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.2 |
0.7 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.2 |
1.4 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.2 |
15.6 |
GO:0007605 |
sensory perception of sound(GO:0007605) |
| 0.2 |
8.6 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.2 |
1.2 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.2 |
1.7 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 |
0.7 |
GO:0099563 |
modification of synaptic structure(GO:0099563) |
| 0.2 |
3.7 |
GO:0030148 |
sphingolipid biosynthetic process(GO:0030148) |
| 0.2 |
0.9 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.2 |
1.8 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.2 |
1.6 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.2 |
2.5 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.2 |
1.6 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.2 |
1.1 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.2 |
4.0 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.2 |
0.4 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.2 |
0.4 |
GO:1902592 |
viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.2 |
0.2 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.2 |
1.5 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.2 |
3.8 |
GO:0000045 |
autophagosome assembly(GO:0000045) |
| 0.2 |
1.5 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.2 |
0.8 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.2 |
1.0 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.2 |
1.0 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.2 |
0.6 |
GO:0042822 |
pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.2 |
0.2 |
GO:1902837 |
amino acid import across plasma membrane(GO:0089718) amino acid import into cell(GO:1902837) |
| 0.2 |
2.2 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.2 |
0.4 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.2 |
0.8 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.2 |
0.8 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.2 |
0.8 |
GO:0042044 |
fluid transport(GO:0042044) |
| 0.2 |
0.8 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.2 |
1.0 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.2 |
1.4 |
GO:0098707 |
ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.2 |
2.1 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.2 |
1.2 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.2 |
1.2 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.2 |
1.0 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.2 |
0.8 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.2 |
1.7 |
GO:2000580 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.2 |
0.9 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.2 |
0.6 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.2 |
0.8 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.2 |
1.1 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.2 |
0.4 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.2 |
0.4 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.2 |
2.2 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.2 |
1.3 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.2 |
2.0 |
GO:0060079 |
excitatory postsynaptic potential(GO:0060079) |
| 0.2 |
0.4 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.2 |
1.1 |
GO:0046103 |
inosine biosynthetic process(GO:0046103) |
| 0.2 |
1.8 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.2 |
0.5 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
| 0.2 |
0.5 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 0.2 |
0.7 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.2 |
0.5 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.2 |
1.9 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.2 |
0.3 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.2 |
0.7 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.2 |
2.0 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.2 |
1.3 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.2 |
3.0 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.2 |
0.7 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.2 |
2.0 |
GO:1903573 |
negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
| 0.2 |
0.2 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.2 |
1.0 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.2 |
0.6 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.2 |
1.1 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.2 |
0.2 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.2 |
0.2 |
GO:0051570 |
regulation of histone H3-K9 methylation(GO:0051570) |
| 0.2 |
0.8 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 |
1.2 |
GO:0033275 |
actin-myosin filament sliding(GO:0033275) |
| 0.2 |
1.1 |
GO:0009301 |
snRNA transcription(GO:0009301) |
| 0.2 |
0.3 |
GO:0090045 |
positive regulation of deacetylase activity(GO:0090045) |
| 0.2 |
0.3 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.2 |
0.5 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.1 |
0.7 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 |
1.6 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 |
1.5 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 |
0.6 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.1 |
1.0 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 |
0.3 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.1 |
0.9 |
GO:0009098 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.1 |
0.4 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.1 |
9.7 |
GO:0000209 |
protein polyubiquitination(GO:0000209) |
| 0.1 |
3.1 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.1 |
0.4 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 |
1.5 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
2.2 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 |
0.4 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.1 |
0.7 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
0.5 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 |
2.5 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.1 |
0.9 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
1.0 |
GO:0036296 |
cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) |
| 0.1 |
0.6 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.1 |
0.8 |
GO:0032196 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
| 0.1 |
1.7 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.1 |
3.5 |
GO:0043631 |
RNA polyadenylation(GO:0043631) |
| 0.1 |
0.5 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.1 |
0.4 |
GO:0030432 |
phasic smooth muscle contraction(GO:0014821) peristalsis(GO:0030432) |
| 0.1 |
0.5 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.1 |
0.6 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
1.3 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.1 |
0.5 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.1 |
0.5 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.1 |
0.4 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.1 |
0.2 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.1 |
0.4 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.1 |
0.5 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.5 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.1 |
0.2 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.5 |
GO:0051930 |
regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.1 |
1.0 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.1 |
0.3 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
0.2 |
GO:0002922 |
positive regulation of humoral immune response(GO:0002922) |
| 0.1 |
0.3 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 |
2.2 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 |
0.3 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 |
1.3 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.1 |
0.1 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
1.5 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.1 |
0.4 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
0.3 |
GO:0045932 |
negative regulation of muscle contraction(GO:0045932) |
| 0.1 |
0.4 |
GO:0048261 |
negative regulation of receptor-mediated endocytosis(GO:0048261) |
| 0.1 |
0.5 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.1 |
1.2 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 |
1.0 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 |
3.2 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.1 |
0.1 |
GO:0071697 |
ectodermal placode formation(GO:0060788) ectodermal placode morphogenesis(GO:0071697) |
| 0.1 |
0.2 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.1 |
0.4 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 |
0.3 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.1 |
0.3 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
1.0 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
2.8 |
GO:0031333 |
negative regulation of protein complex assembly(GO:0031333) |
| 0.1 |
0.4 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.1 |
0.3 |
GO:0034035 |
sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 |
0.3 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.1 |
0.2 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.3 |
GO:0097484 |
dendrite extension(GO:0097484) |
| 0.1 |
0.3 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
0.4 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 |
0.1 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.1 |
1.1 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.1 |
0.2 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.1 |
1.0 |
GO:0050806 |
positive regulation of synaptic transmission(GO:0050806) |
| 0.1 |
0.4 |
GO:0032024 |
positive regulation of insulin secretion(GO:0032024) |
| 0.1 |
0.2 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.6 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.1 |
0.2 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.1 |
0.2 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.1 |
1.2 |
GO:0001881 |
receptor recycling(GO:0001881) |
| 0.1 |
0.2 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.1 |
0.2 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.1 |
0.5 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.1 |
0.1 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.1 |
0.7 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.1 |
0.5 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.1 |
0.2 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.1 |
0.4 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.1 |
0.3 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 |
0.6 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.1 |
0.8 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.1 |
0.5 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.1 |
0.4 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
0.3 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.1 |
0.8 |
GO:0006541 |
glutamine metabolic process(GO:0006541) |
| 0.1 |
0.4 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 |
0.2 |
GO:0031627 |
telomeric loop formation(GO:0031627) telomeric 3' overhang formation(GO:0031860) |
| 0.1 |
0.2 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.6 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.1 |
0.2 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 |
0.5 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.1 |
1.0 |
GO:0048821 |
erythrocyte development(GO:0048821) |
| 0.1 |
0.2 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.4 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.1 |
0.2 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.1 |
0.5 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.1 |
0.3 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.2 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.1 |
0.2 |
GO:1903689 |
regulation of wound healing, spreading of epidermal cells(GO:1903689) |
| 0.1 |
0.2 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 |
0.7 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.0 |
0.4 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.0 |
0.1 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.0 |
0.1 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
1.2 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
| 0.0 |
0.4 |
GO:0030262 |
apoptotic nuclear changes(GO:0030262) |
| 0.0 |
0.8 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.6 |
GO:0097194 |
execution phase of apoptosis(GO:0097194) |
| 0.0 |
0.1 |
GO:0045779 |
negative regulation of bone resorption(GO:0045779) |
| 0.0 |
0.1 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.0 |
0.2 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.0 |
0.1 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.0 |
0.1 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 |
0.1 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.0 |
0.2 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.1 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.0 |
0.2 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 |
0.1 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.0 |
0.0 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.0 |
0.1 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.0 |
0.1 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.1 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.0 |
0.1 |
GO:1902003 |
regulation of beta-amyloid formation(GO:1902003) |
| 0.0 |
0.1 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.0 |
0.1 |
GO:0038042 |
dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
| 0.0 |
0.0 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.0 |
0.2 |
GO:0006152 |
purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
| 0.0 |
0.0 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.2 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.0 |
0.9 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.2 |
GO:0061154 |
endothelial tube morphogenesis(GO:0061154) |
| 0.0 |
0.1 |
GO:0016102 |
retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.0 |
0.1 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.0 |
0.1 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.0 |
0.1 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.0 |
0.4 |
GO:0030048 |
actin filament-based movement(GO:0030048) |
| 0.0 |
0.2 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 |
0.0 |
GO:0008206 |
bile acid metabolic process(GO:0008206) |
| 0.0 |
0.0 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.0 |
0.5 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.0 |
0.1 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 |
0.1 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.3 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 |
0.0 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.0 |
0.1 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 |
0.1 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
| 0.0 |
0.1 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
